View printer-friendly version |
« Back |
September 16, 2003 4:44 p.m. |
![]() |
Teva Announces Approval of Nefazodone HCl Tablets 50 mg, 100 mg, 150 mg, 200 mg and 250 mg |
![]() |
![]() |
Jerusalem, Israel, September 16, 2003 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval of the company's ANDA for Nefazodone Hydrochloride Tablets, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg. Shipment of this product will begin immediately.
|